Hakeem Health, a Saudi Arabia-based healthtech startup developing AI-powered clinical decision support software, has raised $1.65 million in funding.
Investors
The investment round was led by Merak Capital, with participation from Sanabil 500.
Merak Capital is a Saudi Arabia–based investment firm focused on alternative investments and technology-driven businesses across the GCC and broader MENA region. The firm operates across multiple asset classes, including venture capital, private equity, and private credit. Merak invests in sectors such as artificial intelligence, cybersecurity, fintech, gaming, mobility, and digital infrastructure.
Hakeem Health Use of Funds
The company will use the funding to expand HakeemDx deployments across hospitals and healthcare systems in the GCC.
About Hakeem Health
Hakeem Health is a health technology company building an AI-powered clinical decision support infrastructure for healthcare systems in the GCC region. Its flagship platform, HakeemDx, is an AI-powered clinical decision support assistant that helps clinicians turn complex medical research and guidelines into clear, cited summaries at the point of care. It integrates directly with electronic medical records (EMR) and laboratory systems to provide clinicians with real-time, evidence-based medical guidance in both Arabic and English. Headquartered in Saudi Arabia, Hakeem Health operates on a SaaS model, targeting hospitals, universities, and healthcare payers across the Middle East.
Funding Details
Company: Hakeem Health
Raised: $1.65M
Round: Growth
Funding Date: May 2026
Lead Investor: Merak Capital
Additional Investors: Sanabil 500
Company Website: https://hakeem.ae/
Software Category: AI Clinical Decision Support Software / HealthTech SaaS
Source: https://waya.media/merak-capital-leads-1-65-million-round-in-hakeem-health-to-bring-ai-clinical-decision-support-to-gcc-hospitals/